Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00029028.xml
J Pediatr Infect Dis 2010; 05(04): 411-414
DOI: 10.3233/JPI-2010-0274
DOI: 10.3233/JPI-2010-0274
Treatment of central line associated Rhodococcus equi bacteremia with an oral antibiotic regimen in a pediatric oncology patient
Subject Editor:
Further Information
Publication History
28 December 2009
27 June 2010
Publication Date:
28 July 2015 (online)
Abstract
Rhodococcus equi is an emerging pathogen among immunocompromised hosts. Increased incidence has been described in the human immunodeficiency virus/acquired immune deficiency syndrome population, patients immunocompromised due to organ transplantation and in those receiving chemotherapy. Features associated with this case included a sustained bacteremia and delay in recognition of the clinical syndrome due to the intermittent positivity of the blood cultures and initial mis-identification of the organism as a "coryneform" contaminant. The patient was successfully treated with an oral antibiotic regimen after removal of the central catheter.